EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies

Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley, Ryan M Morrow, Kevin A Janssen, Mathieu Quesnel-Vallières, Oz Pomp, Adam A Moverley, Chenchen Li, Nicolas Skuli, Martin Carroll, Jian Huang und 4 weitere

Journal of Clinical Investigation · 17.06.2024 · 134 (12)

DOI: 10.1172/jci175619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 07.05.2024. Verfasst von Xiaolei Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Mitochondria, Mitophagy, Protein Kinases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Leukemia and Lymphoma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Splicing factor mutations are common in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but how they alter cellular functions is unclear. We show that the pathogenic SRSF2 P95H/+ mutation disrupts the splicing of mitochondrial mRNAs, impairs mitochondrial complex I function, and robustly increases mitophagy. We also identified a mitochondrial surveillance mechanism by which mitochondrial dysfunction modifies splicing of the mitophagy activator PINK1 to remove a poison intron, increasing the stability and abundance of PINK1 mRNA and protein. SRSF2 P95H -induced mitochondrial dysfunction increased PINK1 expression through this mechanism, which is essential for survival of SRSF2 P95H/+ cells. Inhibition of splicing with a glycogen synthase kinase 3 inhibitor promoted retention of the poison intron, impairing mitophagy and activating apoptosis in SRSF2 P95H/+ cells. These data reveal a homeostatic mechanism for sensing mitochondrial stress through PINK1 splicing and identify increased mitophagy as a disease marker and a therapeutic vulnerability in SRSF2 P95H mutant MDS and AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteMitochondriaMitophagyProtein KinasesSerine-Arginine Splicing FactorsAnimalsHumansMiceAmino Acid SubstitutionCell Line, TumorHematologic NeoplasmsMutation, MissenseMyelodysplastic SyndromesRNA SplicingPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

AutophagyHematologyLeukemiasMitochondriaOncology

Substanzen

Protein KinasesSerine-Arginine Splicing FactorsPTEN-Induced Putative KinaseSRSF2 protein, humanSRSF2 protein, mouse

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Biochemistry and Biophysics and.
  • Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Coriell Institute for Medical Research, Camden, New Jersey, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Leukemia and Lymphoma Society
  • National Institutes of Health
  • Institute for Translational Medicine and Applied Therapeutics (ITMAT) at the Univ. Pennsylvania
  • Veterans Administration

Zitieren

APA

Liu, X., Devadiga, S. A., Stanley, R. F., Morrow, R. M., Janssen, K. A., Quesnel-Vallières, M., Pomp, O., Moverley, A. A., Li, C., Skuli, N., Carroll, M., Huang, J., Wallace, D. C., Lynch, K. W., Abdel-Wahab, O., & Klein, P. S. (2024). A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies. Journal of Clinical Investigation, 134(12). https://doi.org/10.1172/jci175619

Vancouver

Liu X, Devadiga SA, Stanley RF, Morrow RM, Janssen KA, Quesnel-Vallières M, et al. A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies. Journal of Clinical Investigation. 2024;134(12). doi:10.1172/jci175619

BibTeX
@article{Liu2024,
  author = {Liu, Xiaolei and Devadiga, Sudhish A and Stanley, Robert F and Morrow, Ryan M and Janssen, Kevin A and Quesnel-Vallières, Mathieu and Pomp, Oz and Moverley, Adam A and Li, Chenchen and Skuli, Nicolas and Carroll, Martin and Huang, Jian and Wallace, Douglas C and Lynch, Kristen W and Abdel-Wahab, Omar and Klein, Peter S},
  title = {A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {12},
  doi = {10.1172/jci175619}
}
Kostenlos starten →